Home / Press / CMS Hasche Sigle advises US-based Thermo Fisher Scientific...

CMS Hasche Sigle advises US-based Thermo Fisher Scientific on acquisition of biotech specialist B.R.A.H.M.S. AG

09/09/2009

Cologne – US-listed Thermo Fisher Scientific Inc. has acquired German biotechnology company B.R.A.H.M.S. AG from its management team and HBM BioVentures, a listed Swiss private equity firm.
The 330 million euro transaction requires approval from the competition authorities and is expected to be completed in the next few weeks following approval.

Thermo Fisher Scientific was advised on all aspects of the transaction by a cross-border CMS legal team in six national jurisdictions led by Dr Martin Vorsmann of CMS Hasche Sigle.

B.R.A.H.M.S., which is headquartered in Hennigsdorf near Berlin, is a biotech company with worldwide operations and around 400 employees. It specialises in the production of patented biomarkers for medical diagnostic purposes. The company generated revenues of some EUR 75 million in 2008.

With annual revenues in excess of USD 10 billion, Thermo Fisher Scientific has more than 30,000 employees around the world and is a leading supplier of analytical instruments, laboratory equipment, related technology and services.

Advisers CMS Hasche Sigle:

  • Dr Martin Vorsmann (Lead Partner)
  • Dr Petra Schaffner (M&A)
  • Thierry Randel (Coordination of Due Diligence)
  • Dr Björn Otto
  • Dr Alexandra Janz (both Employment Law)
  • Dr Verena Müller-Seils
  • Dr Carsten Peters (both Corporate)
  • Verena Schäfer (Commercial)
  • Markus Deck
  • Dr Thomas Hirse
  • Ulf Perwitz (all IP)
  • Kai Neuhaus (Antitrust)
  • Dr Stefan El-Barudi
  • Dr Wolfram Schwetzel (both Public Commercial Law).

Lawyers from five other CMS law firms were also involved.

Contact:

Dr Martin Vorsmann
Tel.: +49 221 7716 227
E-mail: Martin.Vorsmann@cms-hs.com

man opens a big door
Press releases
090909_PM_BRAHMS_en
Download
PDF 214.1 kB

Related people

Portrait ofMartin Vorsmann
Dr. Martin Vorsmann
Managing Partner
Berlin